Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Olaf J.L. Loosveld"'
Autor:
Nielka P. van Erp, Mikkjal Skardhamar, Maria Rovithi, Angela Colbers, Sophie L. Gerritse, Olaf J.L. Loosveld, Mariette Labots, Henk M.W. Verheul
Publikováno v:
Molecular Cancer Therapeutics. 18:C079-C079
Background: Optimization of the clinical use of multi-targeting tyrosine kinase inhibitors (TKIs), as sunitinib, is needed to fully exploit their potential antitumor activity. Sunitinib was developed to inhibit angiogenesis-related kinases, but at co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a8cdd5678c59f9f429358872570afe9
https://doi.org/10.1158/1535-7163.targ-19-c079
https://doi.org/10.1158/1535-7163.targ-19-c079
